Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genakumab vs Etoricoxib in Acute Gout Flare
NCT05936268Phase 2Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Primary completion
- Feb 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of genakumab in acute gouty arthritis, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jul 2023; status: completed.
02
Drugs
genakumab
03
Conditions
acute gouty arthritis
Beyond the preview
Go deeper on NCT05936268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05936268.